[FDG-PET and CT in gastrointestinal stromal tumor treated with imatinib].
The combined imaging modality PET/CT is a possible superior tool for evaluation of gastro-intestinal stromal tumor treatment illustrated in a case of a 59-year-old woman responding to imatinib.
Eigtved
Annika I
AI
H:S Rigshospitalet, Diagnostisk Center, PET & Cyklotronenheden, Klinik for Klinisk Fysiologi & Nuklearmedicin, Kobenhavn. eigtved@rh.dk
Berthelsen
Anne Kiil
AK
Kinnander
Christina
C
Krarup-Hansen
Anders
A
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D005260:Female; D019788:Fluorodeoxyglucose F18; D005770:Gastrointestinal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D019275:Radiopharmaceuticals; D017154:Stromal Cells / Q000473:pathology; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D000068877:Imatinib Mesylate